TV

Tichenor Ventures

North America, Texas, United States, Dallas

Description

Tichenor Ventures is a financial organization. Nothing is publicly known about the organization other than this announcement. If you have

Investor Profile

Tichenor Ventures has made 7 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series D (29%)
  • Series A (29%)
  • Series E (14%)
  • Series B (14%)
  • Series C (14%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Oncology
  • Pharmaceutical
  • Biopharma
  • Genetics
  • Health Care
  • Medical Device
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Tichenor Ventures frequently co-invest with?

Auven Therapeutics
North America, Florida, United States, Delray Beach
Co-Investments: 2
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 2
Nextech Invest
Europe, Zurich, Switzerland, Zürich
Co-Investments: 2
RO
North America, California, United States, Oakland
Co-Investments: 2
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 2
The Column Group
North America, California, United States, San Francisco
Co-Investments: 4
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 1
Prospect Venture Partners
North America, California, United States, Palo Alto
Co-Investments: 3
Topspin Partners
North America, New York, United States, Mamaroneck
Co-Investments: 3
Purdue Pharma
North America, Connecticut, United States, Stamford
Co-Investments: 2

Which angels does Tichenor Ventures often collaborate with?

JT
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Tichenor Ventures?

Peloton Therapeutics

Dallas, Texas, United States

Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.

BiotechnologyHealth CareMedical DeviceOncologyPharmaceuticalTherapeutics
Series EFeb 20, 2019
Amount Raised: $150,000,000
Peloton Therapeutics

Dallas, Texas, United States

Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.

BiotechnologyHealth CareMedical DeviceOncologyPharmaceuticalTherapeutics
Series DSep 15, 2016
Amount Raised: $52,400,000
NGM Biopharmaceuticals

South San Francisco, California, United States

NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.

BiopharmaBiotechnologyGeneticsMedical
Series DMar 23, 2015
Amount Raised: $57,500,000
NGM Biopharmaceuticals

South San Francisco, California, United States

NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.

BiopharmaBiotechnologyGeneticsMedical
Series CJul 18, 2013
Amount Raised: $50,000,000
NGM Biopharmaceuticals

South San Francisco, California, United States

NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.

BiopharmaBiotechnologyGeneticsMedical
Series BMar 15, 2010
Amount Raised: $55,389,000
Kolltan Pharmaceuticals

New Haven, Connecticut, United States

Kolltan Pharmaceuticals develops new-generation monoclonal antibody oncology therapeutics.

BiotechnologyMedicalOncologyPharmaceutical
Series AOct 12, 2009
Amount Raised: $5,000,000
Kolltan Pharmaceuticals

New Haven, Connecticut, United States

Kolltan Pharmaceuticals develops new-generation monoclonal antibody oncology therapeutics.

BiotechnologyMedicalOncologyPharmaceutical
Series AJul 31, 2008
Amount Raised: $40,000,000